Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-063966

Director bought 15,000 shares at $0.68 ($10,251)

From the SEC's structured data for this filing

Trades in this filing

THURMAN RANDY H · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-12-21 Purchase : show line 1 in the form +15,000 $0.68 $10,251 15,000 D
Open-market purchases · 15,000 sh · avg $0.68 · $10,251
Loading xslF345X03/doc4.xml…